I don't understand the reason behind the company with the patent on oxymorphone (Opana) and hydrocodone (Vicodon etc) limiting themselves to the American market. I mean usually if you can get FDA approval in America, you can get approved in Europe.
(I just want SO MUCH to be Doctor House and that requires Vicodin in small orange bottles :/ )
I can understand Ketobemidone being removed from markets as it is just so euphoric, that is really isn't a pain medication useful for long term pain management. The rush just from oral is close to being as addictive as the rush from IV cocaine. But then, when I see my grandfather or father in pain from kidney stone and then see them take Ketogan, suddenly they can sit up in the bed, talk, read, be a human being were as before they were just lying down with a face showing agony (and they are old hardcore farmers, who in my grandfathers case have had a hard physical work since he was 10 to he was 70 and preferring to work through pain and sickness instead of going to bed, i.e., they do not complain about pain unless it is unbearable pain way out of the normal 1 to 10 pain scale). Morphine, oxycodone and fentanyl etc. covers a very small mount of the pain according to them, where as Ketogan covers so much more that it doesn't make sense to compare them. And here we are comparing opioids with the strength of Fentanyl with one like Ketobemidone that is about 1,5 times more potent than morphine. It is something about Ketogan doing something to soft tissue or something, I don't know the English medicical term for the Danish "glat muskulatur", which relexes muscles or tissue in the organs making the stones pass more easily.
But the market for treating pain from kidney stone probably isn't that big in comparison to other markets Pfizer have
But Ketobemidone is truely unique and it is hard to explain the euphoria in terms of word you would use to describe the euphoria from oxycodone with.
And this is what makes me wonder how Oxymorphone and Hydrocodone is.
